文献速递脑血管病

血管内卒中治疗后症状性颅内出血的决定因素:一项回顾性队列研究

Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study.
PubMed 文献 · Stroke · 2022-06-08

该研究回顾性分析荷兰MR CLEAN试验与登记数据,纳入3313例前循环大血管闭塞且在发病6.5小时内接受血管内治疗的患者,203例(6%)发生症状性颅内出血。既往抗血小板使用、基线收缩压、基线血糖、术后mTICI评分及手术时长与所有出血结局相关,且不同出血部位的决定因素存在差异,提示机制可能不同。

要点

  • 3313例接受血管内治疗的患者中203例(6%)发生症状性颅内出血。
  • 既往抗血小板使用、基线收缩压、基线血糖、术后mTICI评分及手术时长与所有症状性颅内出血结局相关。
  • 梗死内出血与心肌梗死病史(aOR 1.65)和不良侧支评分(aOR 1.42)相关,梗死外出血与颈内动脉或颈内动脉末端闭塞(较M1,aOR 1.79)相关。

核心结论

  • 若干因素(部分可能可干预)与症状性颅内出血发生相关,进一步研究应探讨调节基线收缩压或血糖水平能否降低症状性颅内出血风险。
  • 症状性颅内出血的决定因素因出血部位而异,支持不同潜在机制的假说。

研究设计与样本

  • 回顾性分析荷兰MR CLEAN试验(Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands)与MR CLEAN登记的数据。
  • 纳入前循环大血管闭塞且在卒中发病6.5小时内接受血管内治疗的成年患者,共3313例。
  • 采用单变量和多变量逻辑回归分析,识别总体症状性颅内出血、梗死脑组织内症状性颅内出血及梗死脑组织外症状性颅内出血的决定因素。

主要发现

  • 3313例纳入患者中203例(6%)发生症状性颅内出血;部位位于梗死脑组织内50例(25%)、梗死脑组织外23例(11%)、梗死内外均有116例(57%),14例(7%)部位数据缺失。
  • 既往抗血小板使用、基线收缩压、基线血浆葡萄糖水平、血管内治疗后改良脑缺血溶栓评分(mTICI)及手术时长与所有结局参数相关。
  • 梗死脑组织内症状性颅内出血的决定因素包括心肌梗死病史(校正比值比1.65[95%CI 1.06-2.56])和不良侧支评分(校正比值比1.42[95%CI 1.02-1.95])。
  • 梗死脑组织外症状性颅内出血的决定因素包括CT血管造影所示的闭塞水平(颈内动脉或颈内动脉末端与M1比较:校正比值比1.79[95%CI 1.16-2.78])。

临床怎么用

  • 原文结论未据此给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Symptomatic intracranial hemorrhage (sICH) is a serious complication after endovascular treatment for ischemic stroke. We aimed to identify determinants of its occurrence and location. METHODS: We retrospectively analyzed data from the Dutch MR CLEAN trial (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) and MR CLEAN registry. We included adult patients with a large vessel occlusion in the anterior circulation who underwent endovascular treatment within 6.5 hours of stroke onset. We used univariable and multivariable logistic regression analyses to identify determinants of overall sICH occurrence, sICH within infarcted brain tissue, and sICH outside infarcted brain tissue. RESULTS: SICH occurred in 203 (6%) of 3313 included patients and was located within infarcted brain tissue in 50 (25%), outside infarcted brain tissue in 23 (11%), and both within and outside infarcted brain tissue in 116 (57%) patients. In 14 patients (7%), data on location were missing. Prior antiplatelet use, baseline systolic blood pressure, baseline plasma glucose levels, post-endovascular treatment modified treatment in cerebral ischemia score, and duration of procedure were associated with all outcome parameters. In addition, determinants of sICH within infarcted brain tissue included history of myocardial infarction (adjusted odds ratio, 1.65 [95% CI, 1.06-2.56]) and poor collateral score (adjusted odds ratio, 1.42 [95% CI, 1.02-1.95]), whereas determinants of sICH outside infarcted brain tissue included level of occlusion on computed tomography angiography (internal carotid artery or internal carotid artery terminus compared with M1: adjusted odds ratio, 1.79 [95% CI, 1.16-2.78]). CONCLUSIONS: Several factors, some potentially modifiable, are associated with sICH occurrence. Further studies should investigate whether modification of baseline systolic blood pressure or plasma glucose level could reduce the risk of sICH. In addition, determinants differ per location of sICH, supporting the hypothesis of varying underlying mechanisms. REGISTRATION: URL: https://www.isrctn.com/; Unique identifier: ISRCTN10888758.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. van der Steen W, van der Ende NAM, van Kranendonk KR, et al. Determinants of Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: A Retrospective Cohort Study. Stroke. 2022. PMID: 35674042. doi:10.1161/STROKEAHA.121.036195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。